Innate Pharma S.A. ADS Company Profile
NASDAQ: IPHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.52-0.07 (-4.40%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Innate Pharma S.A. at a glance
Innate Pharma S.A. ADS (NASDAQ: IPHA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2019. At a market capitalization of $177.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001598599, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Innate Pharma S.A. ADS
- Ticker
- NASDAQ: IPHA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- France
- IPO year
- 2019
- Market cap
- $177.60M
- SEC CIK
- 0001598599
Companies similar to Innate Pharma S.A.
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DTILPrecision BioSciences Inc. | 6.25 | +0.81% | $172.51M | vs IPHA |
| CMPXCompass Therapeutics Inc. | 1.02 | +2.19% | $183.69M | vs IPHA |
| CRDLCardiol Therapeutics Inc. Class A | 1.32 | +0.76% | $160.40M | vs IPHA |
| CHRSCoherus Oncology Inc. | 1.01 | -1.94% | $156.05M | vs IPHA |
| TARAProtara Therapeutics Inc. | 2.59 | +1.37% | $153.06M | vs IPHA |
| VYGRVoyager Therapeutics Inc. | 2.47 | +0.41% | $152.20M | vs IPHA |
| ABOSAcumen Pharmaceuticals Inc. | 2.10 | +3.45% | $151.87M | vs IPHA |
| CGENCompugen Ltd. | 2.15 | -3.15% | $203.66M | vs IPHA |